Augmento Enterprise has been adopted by the esteemed Singapore Health-tech Agency, now known as Synapxe. Currently being implemented in five public hospitals, Augmento accelerates the deployment of medical imaging AI models. A vendor-neutral US FDA approved platform, Augmento Enterprise supports deployment of multimodal imaging AI models. The selection of Augmento for this rollout follows a thorough 1.5-year of evaluation, aligning with Singapore's National AI strategic vision for "Radiology AI." This signifies a significant step forward in integrating advanced AI technologies to enhance healthcare services in Singapore.